Shots:

• Forum participants analyzed key barriers and misinformation around biosimilar adoption to bridge gaps in provider knowledge- generate RWE evidence- streamline biosimilar approval processes- and improve education across safety and efficacy for biologic drugs
• Participants suggested multiple strategies around education- language- RWE- benefit design- legislation- regulations- confidence- and thought sharing to navigate the complexities of the biosimilar terrain
• All findings & recommendations from the AMCP Partnership Forum will be published in an upcoming issue of AMCP’s Journal of Managed Care + Specialty Pharmacy

 ­ Ref: PRNewswire | Image: PR Newswire